Pay to Marwadi

Company Profile

ICRA LTD.

NSE : ICRABSE : 532835ISIN CODE : INE725G01011Industry : RatingsHouse : ICRA
BSE5404.2099.15 (+1.87 % )
PREV CLOSE (Rs.) 5305.05
OPEN PRICE (Rs.) 5411.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 444
TODAY'S LOW / HIGH (Rs.)5266.55 5419.85
52 WK LOW / HIGH (Rs.)4680.05 6244.65
NSE5404.45 108.1 (+2.04 % )
PREV CLOSE(Rs.) 5296.35
OPEN PRICE (Rs.) 5307.90
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5244
TODAY'S LOW / HIGH(Rs.) 5256.10 5422.65
52 WK LOW / HIGH (Rs.)4695.8 6249

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 2.41
TTM EPS (Rs.) 117.85
P/E Ratio 45.86
Book Value (Rs.) 729.30
Face Value (Rs.) 10
MCap (Rs. in Mn) 52157.18
Price/Earning (TTM) 42.95
Price/Sales (TTM) 21.50
Price/Book (MRQ) 7.41
PAT Margin (%) 43.11
ROCE (%) 16.91
Incorporation Year : 1991

Management Info :

Arun Duggal - Chairman Ramnath Krishnan - Managing Director

Registered Office :

Address : B 710 Statesman House,148 Barakhamba Road, ,
New Delhi,
Delhi-110001

Phone : 011- 23357940-45

Website : www.icra.in

Registrar's Details : Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE, MCX
NEWS More
09May05-09-2024$ Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Announcement under Regulati
Announcement under Regulation 30 - Grant of stock options
Announcement under Regulation 30 - Grant of stock options
24Jan01-24-2024$ICRA to join AIRA by subscribing up to 20% stake ICRA to join AIRA by subscri

ICRA has received an approval to join the Association of Indian Rating Agencies (AIRA), by way of subscribing to their shares up to 20% of the paid-up share capital of AIRA, inter alia subject to requisite regulatory approvals. AIRA is an association of credit rating agencies to promote harmonious interactions amongst the credit rating agencies in India. The Board of Directors of the company in its meeting held on January 23, 2024, has approved the proposal.

Joining AIRA by way of subscribing to their shares will help ICRA in participating in the activities of AIRA to promote best practices, create awareness and understanding of credit ratings and contribute towards other objects mentioned in the memorandum of association of AIRA.  The acquisition may be completed in three months, subject to necessary approvals and closing of the offer process including execution of required documents.

ICRA was set up in 1991 by leading financial/investment institutions, commercial banks and financial services companies as an independent and professional investment Information and Credit Rating Agency.


ICRA has received an approval to join the Association of Indian..
16Jan01-16-2024$ICRA informs about outcome of board meeting ICRA informs about outcome o
ICRA has informed that the Board of Directors of ICRA Analytics, a wholly owned subsidiary of ICRA, in the meeting held today, has approved the proposal to invest upto INR 5.5 crore in the preference shares of D2K Technologies India (“D2K”). D2K is a step-down subsidiary of the Company. There will not be any change in the equity shareholding as on date due to subscription of preference shares. Also enclosed a disclosure in this regard. This disclosure is being made in compliance with Regulation 30 of the Listing Regulations, as amended. This will also be hosted on the Company’s website, https://www.icra.in.

The above information is a part of company’s filings submitted to BSE.

ICRA has informed that the Board of Directors of ICRA Analytics..
05Jan01-05-2024$ICRA informs about compliance certificate ICRA informs about complianc
ICRA has informed that it enclosed certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

The above information is a part of company’s filings submitted to BSE.

ICRA has informed that it enclosed certificate under Regulation..
13Nov11-13-2023$ICRA, Dr. Reddy's Laboratories and SJVN to see some action Today ICRA, Dr. Reddy's Laboratori

ICRA has acquired 60% shareholding in D2K Technologies India (D2K), for an aggregate consideration of Rs 15.4 crore on November 10, 2023, and consequently D2K has become a step-down subsidiary of ICRA. D2K is engaged in the business of providing banking and finance solutions, software services to banks and other financial institutions, corporate etc. 

Dr. Reddy's Laboratories has acquired 26% of the paid up equity share capital of O2 Renewable Energy IX (SPV) in the first tranche, in accordance with terms and conditions of the Security Subscription and Shareholders’ Agreement (SSHA). The object of acquisition is to access renewable power through solar and wind power plants through (Inter-State Transmission System) ISTS under captive structure. 

As a Renewable Energy Implementing Agency (REIA), SJVN has successfully concluded its first ever e-reverse auction (e-RA) for selection of RE power developers for supply of 1,500 MW power projects with energy storage system in India.

Alok Industries has entered into facility agreements with Axis Bank for availing a term loan of Rs 1750 crore for the purpose of repayment of existing term loans from banks as a part of financial restructuring; and working capital facility of Rs 100 crore for the purpose of meeting working capital requirements of the company.

Maestros Electronics & Telecommunication System has received Purchase Order from DG Armed Forces Medical Service for Delivery of 338 pieces of Product named METSL TFT Display Cardiac Monitor with defibrillator. Broad consideration or size of the order is Rs 5.89 crore. The said order is expected to be executed by March 8, 2024.

Anant Raj has received approval for the issuance of equity shares or other convertible securities by way of Qualified Institutions Placement (QIP), for an aggregate consideration not exceeding Rs 500 crore only in accordance with the applicable laws including the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, each as amended, subject to receipt of all necessary approvals, if and to the extent required. The Board of Directors of the company at their meeting held on November 11, 2023 have inter-alia considered and approved the same. 

Biocon has reported results for second quarter ended September 30, 2023 (Q2FY24). The company has reported 96.49% fall in its net profit at Rs 34.70 crore for the quarter under review as compared to Rs 987.50 crore for the same quarter in the previous year. Total income of the company decreased marginally by 0.02% at Rs 588.30 crore for Q2FY24 as compared to Rs 588.40 crore for the corresponding quarter previous year. On consolidated basis, the company has reported over 2-fold jump in its net profit at Rs 172.70 crore for Q2FY24 as compared to Rs 81.80 crore for the same quarter in the previous year. Total income of the company increased by 51.84% at Rs 3,620.20 crore for Q2FY24 as compared to Rs 2,384.20 crore for the corresponding quarter previous year.

ICRA has acquired 60% shareholding in D2K Technologies India (D..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit202.06959.3
Gross Profit 232.02 1171.33
Operating Profit 279.941255.08
Net Sales 643.572225.38
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Care Ratings (BSE)
 1103.85 (-0.17%)
M.Cap ( in Cr)
3297.19
CRISIL (BSE)
 4418.25 (-0.71%)
M.Cap ( in Cr)
32307.94
Shareholding Pattern More
PROMOTERS 51.87 %
FI/BANKS/INSURANCE 2.73 %
MUTUAL FUNDS/UTI 17.21 %
NON-INSTITUTION 15.66 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes